Nymox Pharmaceutical Corp. | Ownership
Companies that own Nymox Pharmaceutical Corp.
BlackRock Fund Advisors
1,421,921
2.34%
230,904
0%
06/30/2018
SSgA Funds Management, Inc.
476,234
0.78%
20,621
0%
06/30/2018
Northern Trust Investments, Inc.
272,825
0.45%
21,828
0%
06/30/2018
Wedbush Securities, Inc. (Investment Management)
219,828
0.36%
-28,083
0.07%
06/30/2018
Susquehanna Financial Group LLLP
209,872
0.35%
91,365
0%
06/30/2018
Morgan Stanley & Co. LLC
128,757
0.21%
38,776
0%
06/30/2018
Geode Capital Management LLC
109,786
0.18%
19,284
0%
06/30/2018
BMO Asset Management, Inc.
105,830
0.17%
37,000
0%
06/30/2018
BlackRock Investment Management LLC
99,251
0.16%
-2,149
0%
06/30/2018
Simplex Trading LLC
66,880
0.11%
57,227
0.01%
06/30/2018
| Address |
Bay & Deveaux Streets
Nassau NW
Bahamas
|
|
Employees
|
- |
| Website |
http://www.nymox.com |
| Updated |
07/08/2019 |
| Nymox Pharmaceutical Corp.operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. |
